Knott David M Jr Regeneron Pharmaceuticals, Inc. Transaction History

Knott David M Jr

  • $285 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$548.35 - $738.84 $822,525 - $1.11 Million
-1,500 Reduced 37.5%
2,500 $1.48 Million
Q1 2022

May 16, 2022
SELL
$595.12 - $698.43 $1.19 Million - $1.4 Million
-2,000 Reduced 33.33%
4,000 $2.79 Million
Q4 2021

Feb 11, 2022
BUY
$543.48 - $670.97 $3.26 Million - $4.03 Million
6,000 New
6,000 $3.79 Million

Others Institutions Holding REGN

# of Institutions
1,529
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Knott David M Jr Portfolio

Follow Knott David M Jr and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knott David M Jr, based on Form 13F filings with the SEC.

News

Stay updated on Knott David M Jr with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email